Finch Sued by Ferring Over Patents on Fecal-Transplant Therapy

Ferring and its Rebiotix unit asked a federal court in Delaware to clear RBX2660, their proposed enema-preparation product, of any claims it infringes seven patents held by Finch Therapeutics related to fecal microbiota transplant, or FMT, therapy.

• Ferring is seeking court’s declaration that patents shouldn’t have been issued, can’t be enforced and aren’t infringed, according to complaint filed Wednesday in federal court in Wilmington, Delaware
• RBX2660 is an enema preparation containing a liquid suspension of a diverse consortium of fecal microorganisms, complaint says
  • Treatment will be used to reduce recurrence of Clostridium difficile infection, or CDI, in adults following antibiotic ...